Advances in Cancer Immunotherapy™: A Focus on Monoclonal Antibodies and Antibody-Drug Conjugates

When:  Feb 10, 2022 from 09:00 to 13:00 (CT)
This program will be hosted virtually.

Organizers
:

Christian Capitini, MD – University of Wisconsin-Madison
Hope Rugo, MD – University of California San Francisco Comprehensive Care Center

Program Learning Objectives 

  • Describe the mechanisms of monoclonal antibodies and antibody-drug conjugates.
  • Summarize recent updates in the use of monoclonal antibodies and antibody-drug conjugates clinically and toxicity management for key disease states.
  • Outline common toxicities with monoclonal antibodies and antibody-drug conjugates and their management.


For more information on the program, click below.


PROGRAM INFORMATION

View the SITC Meeting Code of Conduct.